| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |